Pacifen

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Pacifen

Property Description
Active Ingredient Baclofen (beta-(4-chlorophenyl)-GABA)
Form Tablets, Oral Solution, Intrathecal Solution
Pharmacological Class Skeletal Muscle Relaxant
General Purpose Reduction of Spasticity (Muscle Stiffness)
Origin Synthetic (GABA derivative)

What Type of Medicine is Pacifen?

Pacifen is a prescription-only medication whose active ingredient is Baclofen, formally classified as a skeletal muscle relaxant and a selective GABAB receptor agonist. Baclofen is a synthetic compound, chemically derived from the inhibitory neurotransmitter gamma-Aminobutyric acid (GABA). Baclofen is used to help treat stiffness, tightness, and spasms of muscles caused by certain neurological disorders. Pacifen is a single-ingredient product, and the Baclofen formulation is a long-established standard of care, clinically recognized for its efficacy in neurological spasticity management.

Available Forms and General Therapeutic Purpose

Pacifen (Baclofen) is formulated in several high-level preparations, including standard oral tablets and oral solution (liquid), as well as a highly specialized intrathecal solution for administration near the spinal cord. The primary general therapeutic purpose is the reduction of spasticity, which is characterized by chronic, involuntary muscle stiffness, tightness, and spasms. The active ingredient is a widely used and medically confirmed treatment for easing the rigidity associated with conditions like spinal cord lesions or multiple sclerosis. Baclofen is effective in controlling the frequency and severity of muscle spasms.

How Pacifen Affects Muscular Tension

The medicine works by targeting over-excited nerve signals within the spinal cord, where it mimics the inhibitory messenger GABA by activating the GABAB receptors. This mechanism inhibits the transmission of excitatory signals, which effectively serves to dampen exaggerated reflexes that cause continuous, involuntary muscle contraction. This targeted action is the fundamental process by which Pacifen promotes general muscle relaxation and helps alleviate sustained muscular rigidity.

Regulatory References

  1. MedlinePlus: Baclofen Information
  2. PMC: Baclofen for Spasticity

What side effects are possible with Pacifen?

Possible Side Effects and Safety Information

The safety profile of Pacifen (Baclofen) is formally documented in regulatory texts, detailing adverse reactions classified by frequency and body system. The most frequently reported adverse reaction is drowsiness (somnolence), which is classified as very common. Other commonly listed effects include dizziness, general weakness, fatigue, confusion, headache, insomnia, nausea, constipation, and low blood pressure (hypotension).

Adverse effects are categorized into System-Organ Classes (SOC) in official labeling, covering Nervous System Disorders (e.g., ataxia, tremor), Gastrointestinal Disorders, Psychiatric Disorders (e.g., depression, hallucinations), and Renal and Urinary Disorders (e.g., urinary frequency or retention).

Serious Adverse Reactions and Safety Constraints

The regulatory profile highlights the critical risk of Abrupt Drug Withdrawal Syndrome. Sudden cessation can lead to severe adverse reactions, including seizures, hallucinations, rhabdomyolysis, and high fever. The label also documents reports of suicide and suicide-related events and the potential for exacerbation of pre-existing conditions like epilepsy or psychotic disorders.

Specific safety considerations are noted for certain populations. Older adults may exhibit increased sensitivity to the drug’s central nervous system effects, and patients with impaired renal function may experience increased drug effects due to slower elimination. Furthermore, caution is advised when treatment is used in patients where spasticity is relied upon for maintaining upright posture or balance.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose of Pacifen (baclofen) is a severe, life-threatening scenario documented in official regulatory labeling. The clinical profile is characterized by profound Central Nervous System (CNS) and cardiorespiratory depression, necessitating immediate emergency action.

Property Official Regulatory Statement
Documented Overdose Presentations Somnolence, dizziness, confusion, lethargy, loss of consciousness progressing to deep coma, seizures, hypothermia, nausea, and vomiting.
Physiological Systems Affected Severe effects documented in the CNS, resulting in respiratory depression and respiratory failure; and the cardiovascular system, including hypotension and bradycardia (slow heart rate).
Population-Specific Overdose Notes The risk of toxicity is increased in patients with impaired kidney function, as the drug is primarily eliminated via the kidneys.
Emergency-Response Statements Management is limited to symptomatic and supportive measures, as no specific antidote is known in official regulatory documents. Procedures may involve securing the airway, assisted ventilation, and gastric lavage.
When Immediate Medical Help is Required If an overdose is suspected or apparent, the patient must be taken immediately to a hospital for assessment. Immediate contact with emergency medical services is required due to the risk of life-threatening events.

Official regulatory documents define the Pacifen overdose profile by the serious risks of CNS, respiratory, and cardiovascular depression. Given these severe outcomes, regulators mandate the immediate seeking of professional medical assistance and hospitalization for all suspected cases. The absence of a specific antidote shifts the regulatory focus to rapid supportive care to manage the severe symptoms explicitly listed in the prescribing information.

Therapeutic Uses of Pacifen

Pacifen (Baclofen) is commonly used for managing symptoms of muscle stiffness (hypertonia), rigidity, and involuntary spasms caused by central nervous system disorders. It is considered relevant for managing symptoms related to conditions such as Multiple Sclerosis, Spinal Cord Injury, Cerebral Palsy, and certain conditions affecting the brain and nervous system.

By easing chronic muscle over-activity and the frequency of sudden cramping, Pacifen provides supportive therapeutic benefit that may assist with maintaining functional stability and range of motion. This symptomatic relief helps patients cope more steadily with difficult episodes and **supports general well-being during symptomatic phases.


Quick Fact: Support for Muscular Spasticity Symptoms

Pacifen is commonly used for managing symptoms that create noticeable physiological strain and interfere with daily functioning, which provides supportive relief when symptoms interfere with routine activities.**

Eligibility and Restrictions for Use

Who Can and Cannot Use Pacifen?

The population eligibility for Pacifen (Baclofen) is strictly defined by government regulatory agencies based on age, organ function, and specific health conditions.

Contraindications and Restrictions

Pacifen is contraindicated in patients with a known hypersensitivity to baclofen or any excipients in the formulation. Certain regulatory bodies also list active peptic ulceration as a contraindication.

Population Group Regulatory Status
Pediatric Patients Safety and efficacy of the oral form are not established for children under 12 years. Intrathecal use is approved for children 4 years and older.
Older Adults Use requires a cautious, very low dosage schedule due to increased susceptibility to effects and reduced renal clearance.
Renal Impairment Patients with impaired renal function or on chronic dialysis are eligible only under conditions of particularly low dosage and close monitoring.
Pregnancy Use is conditional; administered only if the documented potential benefits outweigh possible hazards to the fetus.
Breastfeeding Use requires caution as the drug passes into breast milk.

Conditions Requiring Extreme Caution

Use of Pacifen requires extreme caution and close surveillance in patients with a history of epilepsy or other convulsive disorders, as the medicine may exacerbate seizures. Caution is also mandatory for patients with psychotic disorders, schizophrenia, or recent stroke due to the risk of exacerbation or poor tolerability.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Pacifen's interaction profile is officially documented to center on pharmacodynamic reinforcement and altered drug clearance. All interaction statements listed below are based strictly on authoritative governmental regulatory documents.


Documented Interaction Outcomes

  • Central Nervous System (CNS) Depressants and Alcohol: The CNS effects of Pacifen are additive to those of alcohol and other CNS depressants, including opioids and benzodiazepines. This documented interaction significantly increases the risk of profound sedation and respiratory depression.
  • Antihypertensives: Co-administration may increase the documented risk of an increased hypotensive effect (a fall in blood pressure).
  • Tricyclic Antidepressants (TCAs): These may potentiate Baclofen’s effects, officially resulting in potential for pronounced muscular hypotonia (muscle weakness).
  • Lithium: Concomitant use has been reported to cause symptoms of toxicity, including severe hyperkinetic movements.

Clearance and Population Notes

Pacifen is eliminated largely unchanged by the kidneys. Therefore, certain interactions relate to its excretion:

  • NSAIDs (e.g., Ibuprofen): Substances that reduce kidney function, such as certain Non-Steroidal Anti-Inflammatory Drugs, may decrease the excretion rate of Pacifen, which could result in higher plasma levels and a risk of systemic toxicity.
  • Impaired Renal Function: This condition is officially noted to cause reduced clearance of Pacifen, substantially increasing the risk of drug accumulation and resulting in neurological signs of overdose, even at low doses.

Mechanism of Action

How Pacifen Works

Pacifen's mechanism of action is defined by Central Spinal Inhibition achieved through targeted molecular interactions and a resulting physiological cascade. Pacifen (Baclofen) initiates its mechanism by selectively binding to and activating the gamma-Aminobutyric acid type B ( GABAB) receptors, G-protein-coupled receptors predominantly located on spinal cord neurons. This agonistic interaction mimics the effect of the inhibitory neurotransmitter, GABA, influencing central nerve cell excitability.


Dual Modulation of Ion Channel Activity

The GABAB activation triggers a dual signaling cascade: it inhibits presynaptic calcium^2+ ( Ca^2+) channels while simultaneously opening postsynaptic potassium^+ ( K^+) channels. The resulting action limits the release of excitatory neurotransmitters from nerve endings and causes the motor neuron membranes to become hyperpolarized (more negative).


Physiological Dampening of Spinal Reflexes

This combined inhibitory effect effectively dampens the activity of the spinal polysynaptic reflex arcs, which mediate the sustained transmission of motor signals. The physiological consequence is a reduction in the overall excitability of the motor system, which establishes a lower intrinsic level of motor output.

Dosage and Administration Information

Official Administration of Pacifen

Pacifen (Baclofen) is administered through two primary, officially approved routes: oral (using tablets, oral solution, or granules) and intrathecal (via continuous infusion into the spinal canal). The standard oral regimen is initiated with a low dose of 5 mg taken three times per day (TID) for the first three days. The dose is then systematically increased by 5 mg per dose every three days, following a staged titration schedule until a satisfactory maintenance dose is reached. The total daily oral dose should not exceed 80 mg for adults.


Contextual Use and Adjustments

To aid in minimizing gastrointestinal irritation, oral formulations are intended to be taken with or after food or milk. Liquid solution formulations require measurement using a calibrated device to ensure proper dosage accuracy. For the highly specialized intrathecal route, chronic infusion is initiated only after a preliminary, single screening bolus dose confirms patient responsiveness.

Administration guidelines mandate starting with a reduced dose in older adults and individuals with impaired kidney function; particularly low daily doses, such as 5 mg, may be appropriate for patients undergoing chronic hemodialysis. For pediatric patients, the maximum daily oral doses are capped at 40 mg for children under eight years of age and 60 mg for children aged eight and over. When treatment is discontinued, the dosage must be progressively reduced over a period of 1 to 2 weeks, following a mandatory gradual withdrawal protocol.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Pacifen

Evidence for Pacifen Use in Multiple Sclerosis-Related Spasticity

Pacifen was studied for managing muscle stiffness and spasms that are characteristic of Multiple Sclerosis (MS). The research base includes numerous Randomized Controlled Trials (RCTs), which are a key study design in medical research, alongside systematic reviews that compile the findings of multiple studies. Research examined outcomes related to physical discomfort and functional imbalance, primarily by monitoring changes in objective measures of muscle tone, such as the Modified Ashworth Scale (MAS), and spasm frequency using tools like the Penn Spasm Scale.

These studies help show what has been observed so far in Adults with MS-related spasticity. Findings describe patterns observed in the measurements of muscle tone and spasm frequency during the study period. For the specialized intrathecal form, reports include patterns observed in long-term open-label studies that monitored patients for several years.

Evidence for Pacifen Use in Spinal Cord Injury-Related Spasticity

Pacifen was evaluated in studies focused on spasticity, muscle rigidity, and spasms following a Spinal Cord Injury (SCI). The research includes systematic reviews and comparative studies for the oral tablet, as well as observational designs for the intrathecal solution. Research explored outcomes related to functional imbalance by monitoring objective measures of muscle tone, spasm frequency, and patient-reported outcomes describing perceived discomfort.

The data show patterns related to observed changes in muscle stiffness scores in this population. The certainty remains low for the oral tablet in specific chronic SCI contexts, as the research is limited by a shortage of high-quality, large-scale RCTs focusing exclusively on chronic SCI.

What Research Gaps and Uncertainties Remain

Evidence highlights what is known—and what is still uncertain—about Pacifen. One key gap is the limited information for long-term outcomes regarding the functional abilities of patients using the oral tablet formulation. Also, the frequent occurrence of dose-limiting adverse events, such as sedation, means that the evaluation of outcomes at higher doses are not fully established in routine practice. Comparative evidence against some current standard-of-care treatments for spasticity is limited.

Key Studies & References

  1. Baclofen: MedlinePlus Drug Information
  2. Baclofen - StatPearls - NCBI Bookshelf (NIH)
  3. Intrathecal baclofen for severe spasticity: A meta-analysis (1997)
  4. Clinical Guideline: Oral Baclofen for Spasticity Management in Children and Young People (2016)
  5. Medications for Spasticity | National MS Society

Frequently Asked Questions (FAQ)

Common questions about Pacifen (FAQ)

Q: Why does Pacifen sometimes cause stomach upset?

A: Gastrointestinal (GI) irritation is a documented effect of this medicine. Official guidelines describe that taking the oral forms with or after food or milk is intended to help manage these effects. Adverse reaction profiles also list nausea and constipation among the commonly reported GI side effects.

Q: Are there any long-term side effects associated with Pacifen use?

A: Official information indicates that long-term use is noted as requiring careful and consistent monitoring. There are documented risks such as the development of tolerance or dependence, and a critical risk of a severe withdrawal syndrome if the medicine is abruptly discontinued. Furthermore, certain effects like ovarian cysts have been observed in women on long-term treatment.

Q: Is it safe to take Pacifen if I have high blood pressure?

A: Official regulatory warnings note that patients with high blood pressure, or hypertension, is a condition that should be monitored closely by a healthcare professional. For this reason, official documents specify that individuals with this condition must be treated cautiously and kept under surveillance due to the potential for the condition to be worsened in some cases.

Q: Is Pacifen safe for use in older adults (seniors)?

A: Official administration guidelines specify that older adults are typically started with a very low dosage and require close medical surveillance. This is because seniors may exhibit increased sensitivity to the medicine’s central nervous system effects due to the drug being eliminated more slowly by the kidneys.

Q: How is Pacifen processed by the body?

A: According to official product information, Pacifen is rapidly absorbed after administration. The majority of the medicine is then excreted largely unchanged through the kidneys. Only a small percentage, approximately 15%, is metabolized or changed by the liver before it is eliminated.

Q: Does Pacifen affect my ability to drive or operate machinery?

A: Regulatory warnings explicitly state that this medicine can cause side effects like drowsiness, sedation, and confusion. Therefore, official warnings state patients should avoid operating automobiles or other potentially dangerous machinery until they know how the medicine affects their personal alertness and coordination.

Q: What is the risk of overdose with Pacifen?

A: The risk of overdose is considered serious and potentially life-threatening. Official sources document that signs of an overdose may include extreme drowsiness, profound muscle weakness, lightheadedness, difficulty breathing, seizures, and loss of consciousness.

Q: What does the FDA label say about Pacifen's efficacy?

A: The official label states that the medicine is used to treat spasticity, which is characterized by muscle stiffness, spasms, and cramping. This therapeutic use applies to spasticity caused by conditions like multiple sclerosis or injuries to the spinal cord.

Q: How quickly does Pacifen usually start to work?

A: The onset time is defined differently for the various forms of the medicine. The onset time for the standard oral tablet is not explicitly detailed in the same way as the specialized intrathecal solution. For the intrathecal solution, the effects are generally observed within one-half hour to one hour.

Q: What is the typical timeframe for Pacifen's effects to wear off?

A: The duration of the medicine’s effect depends on the form taken. For the oral tablet, the effect is related to its elimination half-life, which is approximately 3.5 hours. For the specialized intrathecal solution, the spasm-reducing effects typically last four to eight hours.

Q: If I miss a dose of Pacifen, what is the general recommendation?

A: Official instructions describe what to do if a dose is missed: the general instruction is to take it as soon as the memory returns. However, if the time until the next scheduled dose is less than two hours, the general recommendation is to skip the missed dose entirely. Official information explicitly states never to take two doses simultaneously.

Q: Does Pacifen cause weight gain?

A: According to regulatory adverse reaction profiles, weight gain is listed as a less common or rare side effect. It is also noted that weight loss has been documented as an uncommon event in some individuals.

Q: Can people with liver problems use Pacifen?

A: Official regulatory documents state that caution is advised when this medicine is used in patients suffering from impaired liver function, also known as hepatic impairment.

Q: Is it normal to feel a tingling sensation after starting Pacifen?

A: Tingling, numbness, or a pins-and-needles sensation, medically referred to as paresthesia, is a documented effect. Adverse reaction profiles list this type of sensation as a common side effect of the medicine.

Q: Can Pacifen be crushed or split?

A: The oral tablets are typically manufactured with a score line to allow them to be split, if necessary, for administration. The medicine is also available as an oral solution (liquid) for those who may need an alternative to swallowing a tablet.

Q: Is Pacifen addictive?

A: Regulatory documents explicitly mention that cases of misuse, abuse, and dependence have been reported in connection with this medicine. For this reason, official guidance states that caution and close monitoring are required for patients with any history of substance abuse.

Q: Does Pacifen affect hormone levels?

A: Official documents list documented endocrine-related effects. For women who were treated for up to one year, the development of ovarian cysts is listed as a common finding in the adverse event profile.

Q: Is it normal for Pacifen to cause blurred vision?

A: Blurred vision is documented as a common side effect of this medicine. Other visual disturbances, such as double vision or difficulty with eye accommodation, are also listed in the adverse reaction profiles.

How should Pacifen be stored and disposed of?

Storage Requirements

Pacifen tablets must be stored at controlled room temperature, typically between 20 C and 25 C (68 F and 77 F), and must be protected from freezing.

The medication must be kept in its original container, which should be tightly closed, and stored in a dry place to maintain stability.

Child Safety and Disposal

It is mandatory to store Pacifen out of the sight and reach of children to prevent accidental ingestion.

Unused or expired Pacifen must not be disposed of in household trash or wastewater. Official guidance instructs individuals to ask a pharmacist or utilize available drug take-back programs for proper, regulated disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Pacifen found in:

A-Z Index: